NasdaqCM - Delayed Quote USD
Achieve Life Sciences, Inc. (ACHV)
3.2500
-0.0700
(-2.11%)
At close: June 13 at 4:00:02 PM EDT
3.3982
+0.15
+(4.56%)
After hours: June 13 at 7:56:25 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | -0.35 | -0.29 | -1.32 | -0.82 |
| Low Estimate | -0.46 | -0.34 | -1.46 | -1.72 |
| High Estimate | -0.26 | -0.23 | -1.06 | 1.31 |
| Year Ago EPS | -0.25 | -0.36 | -1.24 | -1.32 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 6 |
| Avg. Estimate | -- | -- | -- | 15.63M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 25.05M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.24 | -0.29 | -0.36 | -0.37 |
| EPS Actual | -0.25 | -0.36 | -0.36 | -0.37 |
| Difference | -0.01 | -0.07 | 0 | -0 |
| Surprise % | -5.93% | -25.00% | 0.00% | -1.17% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.35 | -0.29 | -1.32 | -0.82 |
| 7 Days Ago | -0.34 | -0.29 | -1.31 | -0.72 |
| 30 Days Ago | -0.33 | -0.32 | -1.29 | -0.72 |
| 60 Days Ago | -0.32 | -0.32 | -1.27 | -1.11 |
| 90 Days Ago | -0.3 | -0.3 | -1.16 | -0.83 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 4 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACHV | -41.60% | 18.89% | -6.32% | 38.05% |
| S&P 500 | 13.13% | 2.41% | 7.55% | 14.06% |
Upgrades & Downgrades
| Initiated | Rodman & Renshaw: Buy | 11/14/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/15/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/13/2024 |
| Initiated | JonesTrading: Buy | 4/17/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 4/1/2024 |
| Maintains | Lake Street: Buy to Buy | 3/5/2024 |
Related Tickers
ACXP Acurx Pharmaceuticals, Inc.
0.3050
-7.60%
NGENF NervGen Pharma Corp.
2.7300
-6.92%
SLDB Solid Biosciences Inc.
4.5100
-1.53%
SVRA Savara Inc.
2.2100
-2.21%
DMAC DiaMedica Therapeutics Inc.
3.6500
-6.41%
COCP Cocrystal Pharma, Inc.
1.5400
0.00%
BETRF BetterLife Pharma Inc.
0.0660
0.00%
CSBR Champions Oncology, Inc.
7.66
+3.58%
VTVT vTv Therapeutics Inc.
15.35
-5.91%
RNXT RenovoRx, Inc.
1.3000
-4.41%